The invention discloses an
RNA (Ribonucleic Acid) in-vitro cyclization and rolling circle translation method based on an I-type
intron and an application of the
RNA in-vitro cyclization and rolling circle translation method. According to the invention, a ribonucleic acid construct is obtained by splitting a specific non-complementary region of the I-type
intron, and the preparation of'scarless' (traceless)
circular RNA is realized through a
ribozyme self-splicing principle and can be popularized to other I-type
intron. By optimizing a splitting structure, high-efficiency cyclization can be realized without additionally adding GTP for
catalysis under the condition of no homologous arm. Meanwhile, the original part of the ribonucleic acid construct is optimized, so that the cyclization efficiency is further improved. Particularly, a rolling circle translation (RCT) technical platform based on the CITE sequence is established, and the expression quantity of the
protein or the polypeptide is greatly improved. Through
verification, the cyclization and rolling circle translation method provided by the invention shows potential in vaccine and CAR treatment, and is expected to be used for
clinical treatment of various diseases.